Alex joined MVM in 2005. Prior to joining MVM, he was a member of the life sciences investment team at the Cambridge Gateway Fund. Alex was a consultant with OC&C Strategy Consultants Ltd in London. He has a Ph.D. in Chemistry and a first degree in Natural Sciences from Cambridge University.
Alex is a member of the boards of Vantia Therapeutics Ltd and Xention Ltd.
